DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn
HOMESERVICESABOUT DNA BRIDGES, INC.CLIENTSNEWSROOMCONTACT US

Developed marketing strategy which lead to $12 million USD in private financing

Gregory Landes, PhD | Biotechnology Consultant

Gregory Landes has over 30 years of biopharmaceutical and biotechnology industry experience with broad expertise in antibody drug discovery, antibody preclinical development, antibody drug conjugates, target discovery and validation, molecular biology, genetics, genomics, and biochemistry. He has held positions of significant responsibility with major biopharmaceutical companies including Takeda California (VP, Biological Sciences), Takeda San Francisco (VP, Discovery/Ab Research/Preclinical Development), Lexicon Pharmaceuticals (VP, Biotherapeutics), Abgenix (VP, Product Discovery), Genzyme Corporation (VP, Genetics and Genomics), and Integrated Genetics Incorporated ((Senior Scientist, Genetics and DNA Diagnostics). His broad research experience provides a unique and multi-dimensional perspective on target and drug discovery, which has been leveraged in multiple organizations. Dr. Landes has been an invited speaker at international and national meetings in genomics and antibody drug discovery. He holds a BA in Chemistry and PhD in Biochemistry from the University of Kansas and was awarded a post-doctoral scholarship from the Molecular Biology Institute at UCLA and also received an NIH post-doctoral award while at UCLA. 

 

 

 

"We are already looking into using them again."

- President at a biotechnology company.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.